Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials
Alfredo J Mena Lora(University of Illinois Chicago), Catherine Orrel, Glenda Gray(South African Medical Research Council), Steven Innes, Johan Lombaard, Stephen R. Walsh(Beth Israel Deaconess Medical Center), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Karen L. Kotloff(University of Maryland, Baltimore), Hana M. El Sahly(Baylor College of Medicine), Milagritos Tapia, Paul Goepfert(University of Maryland, Baltimore), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Daniel Reirden, Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Magdelena Sobieszczyk(Columbia University Irving Medical Center), Megan Deming, Rebecca L. Tripp(Fred Hutch Cancer Center), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Nadine Rouphael(Emory University), Jessica E. Long(University of Washington), Sheetal Kassim, Cynthia L. Gay(University of North Carolina at Chapel Hill), Holly Janes(Fred Hutch Cancer Center), Kathleen M. Neuzil(Center for Global Development), Zaheer Hoosain, Dean Follmann(National Institute of Allergy and Infectious Diseases), Jessica Andriesen(Adaptive Biotechnologies (United States)), Pedro Cahn(Hospital San Juan de Dios), Lawrence Corey(Fred Hutch Cancer Center), Ken Mayer, Karan A. Shah(Fred Hutch Cancer Center), Anna P. Durbin, Marcelo Losso(UCLA Medical Center), Colleen F. Kelley(Emory University), Isabel Cassetti, Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mary Marovich(University of Maryland, Baltimore), Ann R. Falsey(University of Rochester), Lindsey R. Baden(Brigham and Women's Hospital), Tina Tong(National Institutes of Health), Yuanyuan Zhang(Westlake University), Jorge Pinto(Universidade Federal de Minas Gerais), Lilly Cheng Immergluck, Richard L. Gorman(Biomedical Advanced Research and Development Authority), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 38
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
|New England Journal of Medicine|2005|2.2k
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k